Cr. Silva et al., Antioxidant action of bixin against cisplatin-induced chromosome aberrations and lipid peroxidation in rats, PHARMAC RES, 43(6), 2001, pp. 561-566
Cisplatin is one of the most active cytotoxic agents in the treatment of ca
ncer, but has serious side effects, inducing nephrotoxicity and chromosome
aberrations. In this study we evaluated the role of the carotenoid bixin on
cisplatin-induced oxidative stress in Wistar rats through three markers of
oxidative damage: chromosome aberrations, glutathione depletion and lipid
peroxidation. The animals were divided into six treatment groups with six r
ats in each (n = 6). The dose of cisplatin (5.0 mg kg(-1) body wt.) was inj
ected i.p. and bixin (2.5 or 5.0 mg kg(-1) body wt.) was given by gavage at
48, 24 h and 10 min before the cisplatin injection. The treatment with the
highest dose of bixin resulted in a statistically significant reduction, b
y about 33%, in cisplatin-induced abnormal metaphases (P < 0.05). A single
dose of cisplatin enhanced the formation of lipid peroxides in 29% and resu
lted in a 29% depletion in renal glutathione 24 h after cisplatin administr
ation (P < 0.05). The pretreatment with bixin reduced the total number of c
hromosome aberrations, inhibited the increase in lipid peroxidation, and in
hibited renal glutathione depletion induced by cisplatin. Since the pretrea
tment with bixin alone was safe, under the present experimental conditions,
the results suggest that bixin may have future clinical application after
further studies. (C) 2001 Academic Press.